Figure 1.

Survival and morbidity analysis of animals used to evaluate the therapeutic potential of amukkara choornam in animal studies. (a) Kaplan-Meier survival plot to evaluate the therapeutic potential of amukkara choornam in animal studies: In group G2 all mice died by 11 days postinfection whereas all mice in group G1, G3, and all but one mice in group G4 survived at the end of the study. Dotted lines represent standard deviations. (b) Mean morbidity score for animal for G1-G4: Morbidity in animals was performed on basis of Morton and Griffith scale. None of the mice in group G1 and G3 exhibited morbidity. Mice in group G2 exhibited high morbidity and mice died once morbidity score reached more than 9. Morbidity in mice in group G4 was like group G2 till day 3 postinfection but it decreased and became comparable to group G1 after treatment with the formulation. *Denotes the level of significance of reduction of morbidity score in comparison with group G2 (all male groups were compared with G2M and all female groups was compared with G2F).